<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1="urn:schemas-microsoft-com:office:smarttags"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 12">
<meta name=Originator content="Microsoft Word 12">
<link rel=File-List href="Docking_files/filelist.xml">
<link rel=Edit-Time-Data href="http://biocomp.health.unm.edu/biomed505/Course/Macromolecules/protein_ligand_docking/Docking_files/editdata.mso">
<link rel=OLE-Object-Data href="http://biocomp.health.unm.edu/biomed505/Course/Macromolecules/protein_ligand_docking/Docking_files/oledata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>Docking</title>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="City"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="place"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>every1</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>every1</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>200</o:TotalTime>
  <o:Created>2008-03-10T22:52:00Z</o:Created>
  <o:LastSaved>2008-03-10T22:52:00Z</o:LastSaved>
  <o:Pages>10</o:Pages>
  <o:Words>2626</o:Words>
  <o:Characters>14971</o:Characters>
  <o:Company>unm</o:Company>
  <o:Lines>124</o:Lines>
  <o:Paragraphs>35</o:Paragraphs>
  <o:CharactersWithSpaces>17562</o:CharactersWithSpaces>
  <o:Version>12.00</o:Version>
 </o:DocumentProperties>
</xml><![endif]-->
<link rel=dataStoreItem href="Docking_files/item0001.xml"
target="Docking_files/props0002.xml">
<link rel=themeData href="http://biocomp.health.unm.edu/biomed505/Course/Macromolecules/protein_ligand_docking/Docking_files/themedata.thmx">
<link rel=colorSchemeMapping href="Docking_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2002TableStyleRules/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="0" Name="endnote reference"/>
  <w:LsdException Locked="false" Priority="0" Name="endnote text"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="0" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="0" Name="Normal (Web)"/>
  <w:LsdException Locked="false" Priority="0" Name="No List"/>
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1107304683 0 0 159 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:left;
	line-height:normal;
	mso-pagination:widow-orphan;
	mso-hyphenate:auto;
	tab-stops:.5in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	mso-bidi-font-weight:normal;}
span.MsoEndnoteReference
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:left;
	line-height:normal;
	mso-pagination:widow-orphan;
	mso-hyphenate:auto;
	tab-stops:.5in;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	mso-bidi-font-weight:normal;}
p
	{mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:115%;
	mso-pagination:widow-orphan;
	mso-hyphenate:none;
	tab-stops:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:AR-SA;
	mso-bidi-font-weight:bold;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Docking_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Docking_files/header.htm") fcs;
	mso-endnote-separator:url("Docking_files/header.htm") es;
	mso-endnote-continuation-separator:url("Docking_files/header.htm") ecs;
	mso-endnote-numbering-style:arabic;}
@page Section1
	{size:8.5in 11.0in;
	margin:.5in .5in .5in .5in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:51930861;
	mso-list-type:hybrid;
	mso-list-template-ids:55847504 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1
	{mso-list-id:243227860;
	mso-list-type:hybrid;
	mso-list-template-ids:-299746038 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2
	{mso-list-id:283930908;
	mso-list-type:hybrid;
	mso-list-template-ids:-1588144852 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l3
	{mso-list-id:414327939;
	mso-list-type:hybrid;
	mso-list-template-ids:-1177934334 67698699 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0D8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4
	{mso-list-id:741608877;
	mso-list-type:hybrid;
	mso-list-template-ids:-1577175046 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5
	{mso-list-id:841042454;
	mso-list-type:hybrid;
	mso-list-template-ids:-1800749090 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6
	{mso-list-id:841312706;
	mso-list-type:hybrid;
	mso-list-template-ids:1162894304 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7
	{mso-list-id:924723955;
	mso-list-type:hybrid;
	mso-list-template-ids:1694280452 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8
	{mso-list-id:1186477641;
	mso-list-type:hybrid;
	mso-list-template-ids:2139536784 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9
	{mso-list-id:1243248845;
	mso-list-type:hybrid;
	mso-list-template-ids:473188612 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10
	{mso-list-id:1597790239;
	mso-list-type:hybrid;
	mso-list-template-ids:215639214 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11
	{mso-list-id:1704597963;
	mso-list-type:hybrid;
	mso-list-template-ids:1951046362 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12
	{mso-list-id:1989819820;
	mso-list-type:hybrid;
	mso-list-template-ids:1587971510 67698691 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
  <o:regrouptable v:ext="edit">
   <o:entry new="1" old="0"/>
   <o:entry new="2" old="0"/>
  </o:regrouptable>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:16.0pt;line-height:115%'>Section II</span></i></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:16.0pt;line-height:
115%'><span style='mso-tab-count:1'>  </span><o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;line-height:
115%'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;line-height:
115%'>The Structure of Macromolecules: </span></b><i style='mso-bidi-font-style:
normal'><span style='font-size:14.0pt;line-height:115%'>Protein-Ligand
Interactions. Molecular Docking (FRED, FlexX)<span style='mso-bidi-font-weight:
bold'> - tutorial<o:p></o:p></span></span></i></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p><i style='mso-bidi-font-style:normal'>Andrei Leitão, Dan C. Fara and Tudor
I. Oprea<o:p></o:p></i></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><u>Objective<o:p></o:p></u></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>To learn how to
use FRED and FlexX software for structure-based virtual screening (docking).<b
style='mso-bidi-font-weight:normal'><span style='font-size:16.0pt;line-height:
115%'><o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>1. Background -</b><b style='mso-bidi-font-weight:
normal'><span style='font-size:14.0pt;line-height:115%'> </span>Nuclear
receptors, hormones, cancer and inhibitors: the biological context of diseases<o:p></o:p></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Nuclear receptor
is a family of proteins that, upon activation, stimulates transcription of DNA
in the nucleus. It can be done in two main ways – see Figure 1:</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>- directly
(named genomic pathway): the hormone binds to the receptor (left part of the
Figure 1) and this complex goes to the nucleus, binds to DNA and promotes the
transcription;</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>- indirectly
(also known as rapid response): the compound binds to a receptor at the
membrane (right part), then second messengers are released and also influence
the transcription, among other effects.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:8.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='line-height:115%'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:253.5pt;
 height:372.75pt'>
 <v:imagedata src="Docking_files/image001.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=338 height=497
src="Docking_files/image002.gif" v:shapes="_x0000_i1025"><![endif]></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>Figure 1</b>. Mechanisms of activation of
nuclear receptor and promotion of transcription into the nucleus (taken from
reference <a style='mso-endnote-id:edn1' href="Docking.htm#_edn1" name="_ednref1" title=""><span
class=MsoEndnoteReference><span style='vertical-align:baseline'><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA;vertical-align:baseline'>[1]</span></span><![endif]></span></span></span></a>)</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>Estradiol
is a hormone that regulates many physiological functions by binding to some
proteins called nuclear receptors. More specifically, it interacts with
estrogen receptors subtypes alpha (ER&#945; or ERa, K<sub>i</sub> = 0.2 nM)<a
style='mso-endnote-id:edn2' href="Docking.htm#_edn2" name="_ednref2" title=""><span
class=MsoEndnoteReference><span style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[2]</span></span><![endif]></span></span></a>
and beta (ER&#946; or ERb, K<sub>i</sub> = 0.5 nM) and, as recently described, with
GPR30 (a transmembrane receptor)<a style='mso-endnote-id:edn3' href="Docking.htm#_edn3"
name="_ednref3" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[3]</span></span><![endif]></span></span></a>.</p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>It
is well-known the importance of ERa to the development of breast cancer. The
growth of the cancer is related to the stimulus of the ERa by the estradiol or
other agonists. It is estimated that 40,460 women and 450 men died of breast
cancer in the USA in 2007.<a style='mso-endnote-id:edn4' href="Docking.htm#_edn4"
name="_ednref4" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[4]</span></span><![endif]></span></span></a> Among
men, it is estimated that the prostate cancer had been the cause of death for
27,050 individuals in 2007 in the USA. This cancer is related to the androgen
receptor (AR)<a style='mso-endnote-id:edn5' href="Docking.htm#_edn5" name="_ednref5"
title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[5]</span></span><![endif]></span></span></a>, in
which testosterone and dihydrotestosterone bind and stimulate the receptor (the
second hormone is much more effective) – see Figure 2.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:4.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='line-height:115%'><!--[if gte vml 1]><v:shape id="_x0000_i1026"
 type="#_x0000_t75" style='width:414pt;height:180pt'>
 <v:imagedata src="Docking_files/image003.jpg" o:title="fig2" croptop="1731f"
  cropbottom="19290f" cropleft="1367f" cropright="1291f"/>
</v:shape><![endif]--><![if !vml]><img width=552 height=240
src="Docking_files/image004.jpg" v:shapes="_x0000_i1026"><![endif]></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:4.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>Figure 2</b>. Part of the biochemical
cascade of metabolism of testosterone (taken from reference <a
style='mso-endnote-id:edn6' href="Docking.htm#_edn6" name="_ednref6" title=""><span
class=MsoEndnoteReference><span style='vertical-align:baseline'><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA;vertical-align:baseline'>[6]</span></span><![endif]></span></span></span></a>)<span
style='font-size:10.0pt;line-height:115%'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>Estrogen
receptor is composed by two subunities (dimmer) in which the hormone estradiol
binds and activates the co-complex, with the binding of a polypeptide sequence
– see Figure 3. This polypeptide sequence that binds to the active form of the
receptor is important for the next step of the DNA transcription. Estradiol
binds to the ERa in a pocket composed by hydrophobic residues, which interact
in the center of the scaffold (not shown in Figure 3 to help visualization),
and also forms hydrogen bonds with glutamate 353 (Glu353), arginine 394
(Arg394) and histidine 524 (His524), besides one water molecule (red sphere in
Figure 3). Inhibitors, such as 4-hydroxytamoxifen and raloxifene, bind into
this cavity, but also interact with aspartate 351 and displace the polypeptide
sequence as shown in Figure 3 for estradiol-ERa.</p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=561 colspan=2 valign=top style='width:420.7pt;border:none;
  border-top:solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>Estradiol – ERa</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=267 valign=top style='width:200.15pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>whole
  structure</p>
  </td>
  <td width=294 valign=top style='width:220.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>close up of
  the pocket &amp; interactions</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=267 valign=top style='width:200.15pt;border:none;border-bottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1027" type="#_x0000_t75" style='width:150pt;height:135.75pt'>
   <v:imagedata src="Docking_files/image005.png" o:title="ERa_estradiol_1GWR_all"/>
  </v:shape><![endif]--><![if !vml]><img width=200 height=181
  src="Docking_files/image006.jpg" v:shapes="_x0000_i1027"><![endif]></p>
  </td>
  <td width=294 valign=top style='width:220.55pt;border:none;border-bottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1028" type="#_x0000_t75" style='width:198.75pt;height:117.75pt'>
   <v:imagedata src="Docking_files/image007.jpg" o:title="ERa_E2"/>
  </v:shape><![endif]--><![if !vml]><img width=265 height=157
  src="Docking_files/image008.jpg" v:shapes="_x0000_i1028"><![endif]></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=561 colspan=2 valign=top style='width:420.7pt;border:none;
  mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>4OHtamoxifen –
  ERRg</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=267 valign=top style='width:200.15pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>structure of
  the target with ligand</p>
  </td>
  <td width=294 valign=top style='width:220.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>hydrophilic
  interactions</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=267 valign=top style='width:200.15pt;border:none;border-bottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1029" type="#_x0000_t75" style='width:2in;height:135pt'>
   <v:imagedata src="Docking_files/image009.png" o:title="ERRg_ohtamoxifen"/>
  </v:shape><![endif]--><![if !vml]><img width=192 height=180
  src="Docking_files/image010.jpg" v:shapes="_x0000_i1029"><![endif]></p>
  </td>
  <td width=294 valign=top style='width:220.55pt;border:none;border-bottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1030" type="#_x0000_t75" style='width:155.25pt;height:141pt'>
   <v:imagedata src="Docking_files/image011.jpg" o:title="ERRg_OHT"/>
  </v:shape><![endif]--><![if !vml]><img width=207 height=188
  src="Docking_files/image012.jpg" v:shapes="_x0000_i1030"><![endif]></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=561 colspan=2 valign=top style='width:420.7pt;border:none;
  mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>Dihydrotestosterone
  – AR</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=267 valign=top style='width:200.15pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>structure of
  the target with ligand</p>
  </td>
  <td width=294 valign=top style='width:220.8pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'>hydrophilic
  interactions</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8;mso-yfti-lastrow:yes'>
  <td width=267 valign=top style='width:200.15pt;border:none;border-bottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1031" type="#_x0000_t75" style='width:145.5pt;height:107.25pt'>
   <v:imagedata src="Docking_files/image013.png" o:title="AR_DHT_closeup"/>
  </v:shape><![endif]--><![if !vml]><img width=194 height=143
  src="Docking_files/image014.jpg" v:shapes="_x0000_i1031"><![endif]></p>
  </td>
  <td width=294 valign=top style='width:220.55pt;border:none;border-bottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1032" type="#_x0000_t75" style='width:198pt;height:102.75pt'>
   <v:imagedata src="Docking_files/image015.png" o:title="AR_DHT_ligH"/>
  </v:shape><![endif]--><![if !vml]><img width=264 height=137
  src="Docking_files/image016.jpg" v:shapes="_x0000_i1032"><![endif]></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:6.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>Figure 3</b>. Interaction patterns of
nuclear receptors and ligands</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:10.0pt;line-height:115%'>Dashed lines represent proposed hydrogen
bond interactions with the amino acids. Ligands and important amino acids in
the pocket are shown as sticks, colored by atom type. Cartoon representations
of the protein were colored based on the structure: helices (pink), loops
(light green), &#946;-sheets (yellow). Polypeptide sequence is shown as lines.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Other compounds
can also interact with these targets, and they can be agonists, partial
agonists, inverse agonists and antagonists. These molecules modulate the
outcome of the nuclear receptor response.</p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>New
selective inhibitors are needed to interfere with this unbalanced biological
system and, consequently, to stop the cancer growth. Finding active compounds
is not a difficult task, but the problem arises when it is necessary to
identify selective compounds<a style='mso-endnote-id:edn7' href="Docking.htm#_edn7"
name="_ednref7" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[7]</span></span><![endif]></span></span></a>,
because some of these nuclear receptors have similar structure, i.e. when the
compound has high affinity to one receptor, it can also bind to others (the
lack of selectivity can be related to the some of the side effects of these
compounds). For example, the drug 4-hydroxytamoxifen (also written as
4-OHtamoxifen, OH-tamoxifen) is used to treat breast cancer, but administered
as a pro-drug, tamoxifen, binds to three other different nuclear receptors: ERa
and ERb (K<sub>i</sub> around 0.5 nM) and also estrogen-related receptor gamma
(ERRg) with high affinity (EC<sub>50</sub> = 15 nM). The physiological function
of ERRg is not well established, but it is surprisingly that this receptor does
not bind estradiol with high affinity, although it is very similar to ERa, with
the same pattern of binding to 4-hydroxytamoxifen – see Figure 3.</p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>The
newly potentially active and selective molecules are studied based on the way
they interact with the biological target<a style='mso-endnote-id:edn8'
href="Docking.htm#_edn8" name="_ednref8" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[8]</span></span><![endif]></span></span></a>.
For example, estradiol establishes hydrogen bonds with histidine, glutamate and
arginine, but there are also lypophilic interactions with many residues in the
middle of the core. 4-hydroxytamoxifen also establishes hydrogen bonds to
histidine and glutamate for both ERa and ERRg, but instead of interacting with
histidine at the bottom of the pocket, it forms hydrogen bond with aspartate at
the top – see Figure 3. Dihydrotestosterone is not an excellent binder to ERa
(K<sub>i</sub> = 69.9 nM) because it lacks a hydroxy group in one end – see Figure
2. In contrast, it is the hormone that binds with high affinity to the androgen
receptor (K<sub>i</sub> = 0.3 nM), even better than testosterone (K<sub>i</sub>
= 1.4 nM). Non-steroidal compounds also bind to this receptor, like metribolone
(also known as R1881), which is a potent agonist molecule.<a style='mso-endnote-id:
edn9' href="Docking.htm#_edn9" name="_ednref9" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[9]</span></span><![endif]></span></span></a></p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>Those
studies are primarily done by using many different kinds of computer
simulations that comprise, for example, the representation of the target-ligand,
the three-dimensional simulation of the receptor and its interactions with the
ligands (Figure 3) and also the study and selection of new compounds based on
similarities with known binders (this field of work is known as
cheminformatics). All these topics will be further discussed.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>2. Molecular docking using FRED and FlexX -
tutorial</b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Docking is a
tool commonly used to discover new chemicals based on the interaction between
the ligand and the biological target in the three-dimensional (3D) space. It
comes from the knowledge that there are somewhat complementary interactions
between the ligand and the biological target. Better ligands have lower
(negative) interaction energy and it can be captured by what is known as
scoring function. However, the scoring functions give only a rough idea about
the ligand – target system.</p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>For
instance, two molecules are similar to each other (A and B) but A interacts
with the protein (C) way better than B – see Figure 4. A good docking program
can capture this information accurately. To accomplish that, the program must
change the position of the ligand to fit it into the pocket of the protein –
see Figure 4, part 1 – and to detect the correct ligand-protein interactions, while
it discards bad solutions – see Figure 4, part 2.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:shape
 id="_x0000_i1033" type="#_x0000_t75" style='width:438.75pt;height:241.5pt'
 o:ole="">
 <v:imagedata src="Docking_files/image017.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=585 height=322
src="Docking_files/image018.gif" v:shapes="_x0000_i1033"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="ISISServer" ShapeID="_x0000_i1033"
  DrawAspect="Content" ObjectID="_1266673125">
 </o:OLEObject>
</xml><![endif]--></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:6.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>Figure 4</b>. Interaction profiles for
molecules A and B and the docking protocol</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>The
main idea of ligand-protein interaction comes from the lock-and-key model,
where both ligand and protein are rigid bodies, as shown in Figure 4. In
reality, the ligand and protein are not rigid, one or even both of them being flexible
during the process of recognition. There are many different docking programs that
try to solve this apparent simple question (in fact, none of them can be used
to all systems). </p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>Here
you will use two different programs, FRED and FlexX, to dock small molecules
from a 3D database (199 compounds) into three biological targets: estrogen
receptor alpha (ERa), estrogen-related receptor gamma (ERRg) and androgen
receptor (AR). The outcome of each ligand-receptor interaction will be
automatically analyzed by a scoring function which, in turn, ranks the
compounds.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>2.1 FRED<o:p></o:p></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>This program
uses the lock-and-key idea presented above. A bunch of conformations from each
ligand interacts with the receptor and the best solution is stored to be ranked
at the end of the process. Programs like this one give results much faster than
others that deal with the flexibility of the compound.</p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Connect
     to hatch.health.unm.edu, your account</li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Type
     <b style='mso-bidi-font-weight:normal'>cp –r /home/app/tutorial-docking ~</b>
     </li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Go
     to the tutorial directory (type <b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>cd ~/tutorial_docking</span></b>
     on the shell) and see what is in there (use the list command: <b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:115%'>ls</span></b>). The following three directories are
     listed: (i) <i style='mso-bidi-font-style:normal'>compounds</i>, (ii) <i
     style='mso-bidi-font-style:normal'>FlexX</i>, and (iii) <i
     style='mso-bidi-font-style:normal'>fred</i>. The first one contains the
     compound database, with the 3D structures generated and a set of
     conformations for each one. Open <i style='mso-bidi-font-style:normal'>fred</i>
     directory (<b style='mso-bidi-font-weight:normal'><span style='font-size:
     11.0pt;line-height:115%'>cd fred</span></b>) and note that each one of the
     three directories (ERa, ERRg and AR) contains the files needed to run the
     program. Go to ERa (type <b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>cd ERa</span></b>) and list the
     files again (<b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>ls</span></b>): 3ERT.oeb is the
     receptor already prepared; OHtamoxifen.mol2 is the ligand; setup.txt has
     all the information necessary to run the program; and the directory result
     is empty (if you want, you can check it before running FRED). Now let us
     run the program: <b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>fred -param setup.txt</span> </b>It
     takes time to dock the entire database (around 15 minutes) because this
     kind of calculation is much more complex (see Figure 4 with the
     procedure). <b style='mso-bidi-font-weight:normal'><o:p></o:p></b></li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Go
     to the directory result (<b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>cd results</span></b>) to check
     it (<b style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:115%'>ls</span></b>). Many files were created, but you will
     analyze the consensus_docked.mol2 (with the conformations of the compounds
     docked into the site) and consensus_scores.txt (the ranking of the
     compounds).</li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Open
     the file to check the results: <b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>gedit consensus_scores.txt &amp;</span></b>.
     Try to find the position of the compounds that were added to the set
     (ohtamoxifen is the best ranked, estradiol - the 69<sup>th</sup>, while dihydrotestoterone
     is the worst of them, as expected). The top 5 compounds will be analyzed
     more deeply, but it can also be done to other compounds. </li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Close
     the gedit window. </li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l7 level1 lfo1'>Open
     a visualization program named VIDA to see how good the compounds fit the
     pocket of the receptor: type <b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>vida</span></b> on the shell. An
     interface like the one shown in Figure 5a will open. The program has the
     following layout (if the layout is different, Click on the button showed
     by the red circle, Figure 5a):</li>
</ul>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l10 level1 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>the top part contains the main menu and many
options to change the display (Figure 5a. number 1)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l10 level1 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>the left part harbors the ligand list and other
information (two white windows)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l10 level1 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>the main windows (middle black one) is where you
visualize the compounds</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l10 level1 lfo2'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>the right window has some visualization buttons</p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l9 level1 lfo3'>Click
     on ‘Tools’ and ‘FRED view’ on the menu (Figure 5a, number 1). The box
     shows the options to fill in (number 2):</li>
</ul>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l6 level1 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Protein: 3ERT.oeb (click in ‘browse’ and go one
directory up, number 3)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l6 level1 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Reference ligand: OHtamoxifen.mol2 (click in
‘browse’)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l6 level1 lfo4'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Docking results: consensus_docked.mol2 (click in
‘browse’ and click on ‘result’). The result will appear on the main window,
loading the list of compounds docked (Figure 5b). Now it is time to see how
good the results are. </p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l9 level1 lfo3'>Hide
     the hydrogens by clicking on the H symbol, highlighting the icon (skip
     this step if hydrogens are not shown) – see Figure 5b, number 1. Look at
     the main window with the structures. You are seeing two structures (green
     is the tamoxifen from the X-ray, the template, and gray the docked one).
     They are inside the ERa pocket, shown by the surface, and there are some
     hydrogen bonds with amino acids, highlighted by the green dashed lines
     (number 2).</li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l9 level1 lfo3'>Hide
     the standard compound by clicking on the green balls in the left panel
     (number 3). Now, only the docked compound (gray carbons) is shown. As can
     be seen only a weaker hydrogen bond interaction is shown, because the
     dashed yellow line is finer than the standard compound-ERa interactions. These
     hydrogen bonds with arginine and glutamate are important for those
     compounds, because it helps the stabilization of the co-complex. To rotate
     the co-complex, drag the mouse with the left button pressed. There is no
     hydrogen bond with histidine because of the lack of complementarities. Another
     hydrogen bond, with aspartate 351, is not shown on the standard X-ray
     structure (green) because of the distance between the amino group and the
     side chain of the amino acid. In other X-rays this hydrogen bond is better
     defined for antagonist compounds.</li>
</ul>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>You can also
check other structures by clicking on the codes or in the green ball column –
see Figure 5b, number 3. Remember to hide the latest compound opened before
looking at the next one in order to facilitate the visualization (do not do
that if you want to compare the structures).</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='text-align:justify;line-height:115%'>(a)</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:group
 id="_x0000_s1055" style='position:absolute;left:0;text-align:left;
 margin-left:69pt;margin-top:7.2pt;width:219pt;height:118pt;z-index:2'
 coordorigin="3180,1860" coordsize="4380,2360">
 <v:line id="_x0000_s1026" style='position:absolute;flip:x y' from="3492,1860"
  to="3744,2088" o:regroupid="3" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line><v:shapetype id="_x0000_t202" coordsize="21600,21600" o:spt="202"
  path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="_x0000_s1032" type="#_x0000_t202" style='position:absolute;
  left:3636;top:2016;width:312;height:396' o:regroupid="3" filled="f"
  stroked="f">
  <v:textbox style='mso-next-textbox:#_x0000_s1032'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;color:white'>1<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:shape><v:line id="_x0000_s1036" style='position:absolute;flip:x' from="7008,2520"
  to="7368,2700" o:regroupid="3" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line><v:shape id="_x0000_s1037" type="#_x0000_t202" style='position:absolute;
  left:7368;top:2340;width:192;height:396' o:regroupid="3" filled="f"
  stroked="f">
  <v:textbox style='mso-next-textbox:#_x0000_s1037'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;color:white'>2<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:shape><v:line id="_x0000_s1040" style='position:absolute;flip:x' from="6590,3870"
  to="6820,4220" o:regroupid="3" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line><v:shape id="_x0000_s1041" type="#_x0000_t202" style='position:absolute;
  left:6800;top:3650;width:192;height:396' o:regroupid="3" filled="f"
  stroked="f">
  <v:textbox style='mso-next-textbox:#_x0000_s1041'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;color:white'>3<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:shape><v:oval id="_x0000_s1053" style='position:absolute;left:3180;top:1932;
  width:228;height:240' o:regroupid="3" filled="f" strokecolor="red"
  strokeweight="1.5pt"/>
</v:group><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:
absolute;z-index:2;left:0px;margin-left:91px;margin-top:1px;width:295px;
height:173px'><img width=295 height=173 src="Docking_files/image019.gif"
v:shapes="_x0000_s1055 _x0000_s1026 _x0000_s1032 _x0000_s1036 _x0000_s1037 _x0000_s1040 _x0000_s1041 _x0000_s1053"></span><![endif]><!--[if gte vml 1]><v:shape
 id="_x0000_i1034" type="#_x0000_t75" style='width:431.25pt;height:251.25pt'>
 <v:imagedata src="Docking_files/image020.jpg" o:title="vida_interface"
  cropbottom="2385f"/>
</v:shape><![endif]--><![if !vml]><img width=575 height=335
src="Docking_files/image021.jpg" v:shapes="_x0000_i1034"><![endif]></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>(b)</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><!--[if gte vml 1]><v:group
 id="_x0000_s1056" style='position:absolute;left:0;text-align:left;
 margin-left:43pt;margin-top:38.3pt;width:389.6pt;height:129.6pt;z-index:1'
 coordorigin="2660,8340" coordsize="7792,2592">
 <v:line id="_x0000_s1044" style='position:absolute;flip:x y' from="10080,10356"
  to="10332,10584" o:regroupid="1" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line><v:shape id="_x0000_s1045" type="#_x0000_t202" style='position:absolute;
  left:10260;top:10536;width:192;height:396' o:regroupid="1" filled="f"
  stroked="f">
  <v:textbox style='mso-next-textbox:#_x0000_s1045'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt'>1<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:shape><v:line id="_x0000_s1046" style='position:absolute;flip:x' from="2660,8530"
  to="3020,8530" o:regroupid="1" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line><v:shape id="_x0000_s1047" type="#_x0000_t202" style='position:absolute;
  left:2970;top:8340;width:192;height:396' o:regroupid="1" filled="f"
  stroked="f">
  <v:textbox style='mso-next-textbox:#_x0000_s1047'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt'>3<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:shape><v:line id="_x0000_s1048" style='position:absolute' from="4014,10536"
  to="4440,10775" o:regroupid="1" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line><v:shape id="_x0000_s1049" type="#_x0000_t202" style='position:absolute;
  left:3760;top:10316;width:192;height:396' o:regroupid="1" filled="f"
  stroked="f">
  <v:textbox style='mso-next-textbox:#_x0000_s1049'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;color:white'>2<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:shape><v:line id="_x0000_s1050" style='position:absolute;flip:y' from="4018,10470"
  to="4618,10540" strokecolor="red" strokeweight="3pt">
  <v:stroke endarrow="block"/>
 </v:line></v:group><![endif]--><![if !vml]><span style='mso-ignore:vglayout;
position:absolute;z-index:1;left:0px;margin-left:54px;margin-top:51px;
width:525px;height:177px'><img width=525 height=177
src="Docking_files/image022.gif" v:shapes="_x0000_s1056 _x0000_s1044 _x0000_s1045 _x0000_s1046 _x0000_s1047 _x0000_s1048 _x0000_s1049 _x0000_s1050"></span><![endif]><!--[if gte vml 1]><v:shape
 id="_x0000_i1035" type="#_x0000_t75" style='width:431.25pt;height:261.75pt'>
 <v:imagedata src="Docking_files/image023.jpg" o:title="result_ohtamoxifen"
  cropbottom="2414f"/>
</v:shape><![endif]--><![if !vml]><img width=575 height=349
src="Docking_files/image024.jpg" v:shapes="_x0000_i1035"><![endif]></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>Figure 5</b>. VIDA interface and docking
results for ERa</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:10.0pt;line-height:115%'>Figure 5b: Note that when you select
a compound the structure of the ligand appears at the bottom left corner<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l8 level1 lfo5'>Go
     to the ERRg (<b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>cd ../../ERRg</span></b>) and also
     AR directories and repeat the previous given steps.</li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l8 level1 lfo5'>Open
     the results. </li>
</ul>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Table 1 shows
the top 5 compounds for those three results.</p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Table 1. Ranking
of the best 5 compounds for each target</p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=523
 style='width:392.1pt;margin-left:4.8pt;border-collapse:collapse;border:none;
 mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;height:12.75pt'>
  <td width=74 nowrap valign=bottom style='width:55.3pt;border-top:solid windowtext 2.25pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><b
  style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
  115%;font-family:"Arial","sans-serif"'>Name<o:p></o:p></span></b></p>
  </td>
  <td width=86 nowrap valign=bottom style='width:64.75pt;border-top:solid windowtext 2.25pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext 2.25pt;mso-border-bottom-alt:solid windowtext 1.0pt;
  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><b
  style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
  115%;font-family:"Arial","sans-serif"'>Consensus Score AR<o:p></o:p></span></b></p>
  </td>
  <td width=87 valign=bottom style='width:65.3pt;border-top:solid windowtext 2.25pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-left-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><b
  style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
  115%;font-family:"Arial","sans-serif"'>Name<o:p></o:p></span></b></p>
  </td>
  <td width=86 valign=bottom style='width:64.75pt;border-top:solid windowtext 2.25pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext 2.25pt;mso-border-bottom-alt:solid windowtext 1.0pt;
  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><b
  style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
  115%;font-family:"Arial","sans-serif"'>Consensus Score ERa<o:p></o:p></span></b></p>
  </td>
  <td width=87 valign=bottom style='width:65.3pt;border-top:solid windowtext 2.25pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-left-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><b
  style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
  115%;font-family:"Arial","sans-serif"'>Name<o:p></o:p></span></b></p>
  </td>
  <td width=102 valign=bottom style='width:76.7pt;border-top:solid windowtext 2.25pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><b
  style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
  115%;font-family:"Arial","sans-serif"'>Consensus Score ERRg<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;height:12.75pt'>
  <td width=74 nowrap valign=bottom style='width:55.3pt;border:none;mso-border-top-alt:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10314457<o:p></o:p></span></p>
  </td>
  <td width=86 nowrap valign=bottom style='width:64.75pt;border:none;
  border-right:solid windowtext 1.0pt;mso-border-top-alt:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext 1.0pt;mso-border-right-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>7<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-top-alt:solid windowtext 1.0pt;
  mso-border-left-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>ohtamoxifen<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext 1.0pt;mso-border-top-alt:solid windowtext 1.0pt;
  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>0<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-top-alt:solid windowtext 1.0pt;
  mso-border-left-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10405011<o:p></o:p></span></p>
  </td>
  <td width=102 valign=bottom style='width:76.7pt;border:none;mso-border-top-alt:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>5<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2;height:12.75pt'>
  <td width=74 nowrap valign=bottom style='width:55.3pt;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10041071<o:p></o:p></span></p>
  </td>
  <td width=86 nowrap valign=bottom style='width:64.75pt;border:none;
  border-right:solid windowtext 1.0pt;mso-border-right-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>7<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11597178<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid windowtext 1.0pt;
  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>6<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10689508<o:p></o:p></span></p>
  </td>
  <td width=102 valign=bottom style='width:76.7pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>14<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;height:12.75pt'>
  <td width=74 nowrap valign=bottom style='width:55.3pt;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11722940<o:p></o:p></span></p>
  </td>
  <td width=86 nowrap valign=bottom style='width:64.75pt;border:none;
  border-right:solid windowtext 1.0pt;mso-border-right-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>7<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10500501<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid windowtext 1.0pt;
  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>7<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11597178<o:p></o:p></span></p>
  </td>
  <td width=102 valign=bottom style='width:76.7pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>15<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;height:12.75pt'>
  <td width=74 nowrap valign=bottom style='width:55.3pt;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10470789<o:p></o:p></span></p>
  </td>
  <td width=86 nowrap valign=bottom style='width:64.75pt;border:none;
  border-right:solid windowtext 1.0pt;mso-border-right-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>16<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11634313<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid windowtext 1.0pt;
  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>ohtamoxifen<o:p></o:p></span></p>
  </td>
  <td width=102 valign=bottom style='width:76.7pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>18<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5;mso-yfti-lastrow:yes;height:12.75pt'>
  <td width=74 nowrap valign=bottom style='width:55.3pt;border:none;border-bottom:
  solid windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10402442<o:p></o:p></span></p>
  </td>
  <td width=86 nowrap valign=bottom style='width:64.75pt;border:none;
  border-bottom:solid windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:
  12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>21<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-bottom:solid windowtext 2.25pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11725333<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-bottom:solid windowtext 2.25pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>16<o:p></o:p></span></p>
  </td>
  <td valign=bottom style='border:none;border-bottom:solid windowtext 2.25pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10449190<o:p></o:p></span></p>
  </td>
  <td width=102 valign=bottom style='width:76.7pt;border:none;border-bottom:
  solid windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>
  <p class=MsoNormal style='text-align:justify;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>22<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Try to compare
the best five ranked compounds with the standard ones in the study (Figure 6). Note
that they interact similarly with the target because they share some similar
features with the scaffold.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:6.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>4-hydroxytamoxifen<o:p></o:p></span></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11597178</span></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>10500501</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1036" type="#_x0000_t75" style='width:126.75pt;height:134.25pt'>
   <v:imagedata src="Docking_files/image025.png" o:title="ohtamoxifen"
    croptop="11426f" cropleft="2216f" cropright="13139f"/>
  </v:shape><![endif]--><![if !vml]><img width=169 height=179
  src="Docking_files/image026.jpg" v:shapes="_x0000_i1036"><![endif]></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1037" type="#_x0000_t75" style='width:129pt;height:134.25pt'>
   <v:imagedata src="Docking_files/image027.png" o:title="11597178" croptop="10904f"
    cropbottom="2923f" cropleft="4339f" cropright="11906f"/>
  </v:shape><![endif]--><![if !vml]><img width=172 height=179
  src="Docking_files/image028.jpg" v:shapes="_x0000_i1037"><![endif]></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1038" type="#_x0000_t75" style='width:138.75pt;height:135pt'>
   <v:imagedata src="Docking_files/image029.png" o:title="10500501" croptop="11683f"
    cropbottom="714f" cropleft="1128f" cropright="10955f"/>
  </v:shape><![endif]--><![if !vml]><img width=185 height=180
  src="Docking_files/image030.jpg" v:shapes="_x0000_i1038"><![endif]></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11634313</span></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>11725333</span></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Arial","sans-serif"'>estradiol<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes'>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1039" type="#_x0000_t75" style='width:127.5pt;height:135pt'>
   <v:imagedata src="Docking_files/image031.png" o:title="11634313" croptop="10439f"
    cropleft="1725f" cropright="12072f"/>
  </v:shape><![endif]--><![if !vml]><img width=170 height=180
  src="Docking_files/image032.jpg" v:shapes="_x0000_i1039"><![endif]></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1040" type="#_x0000_t75" style='width:140.25pt;height:134.25pt'>
   <v:imagedata src="Docking_files/image033.png" o:title="11725333" croptop="11678f"
    cropbottom="2798f" cropleft="517f" cropright="12450f"/>
  </v:shape><![endif]--><![if !vml]><img width=187 height=179
  src="Docking_files/image034.jpg" v:shapes="_x0000_i1040"><![endif]></p>
  </td>
  <td width=197 valign=top style='width:2.05in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:115%'><!--[if gte vml 1]><v:shape
   id="_x0000_i1041" type="#_x0000_t75" style='width:141.75pt;height:134.25pt'>
   <v:imagedata src="Docking_files/image035.png" o:title="estradiol" croptop="12941f"
    cropbottom="2042f" cropright="12886f"/>
  </v:shape><![endif]--><![if !vml]><img width=189 height=179
  src="Docking_files/image036.jpg" v:shapes="_x0000_i1041"><![endif]></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-size:6.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>Figure 6</b>. Comparison of the top 5 docked
compounds and estradiol in ERa</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='margin-left:.5in;text-align:justify;text-indent:-.25in;
line-height:115%;mso-list:l3 level1 lfo9'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Parameters to use in VIDA after running the
docking program for ERRg target:</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l5 level1 lfo10'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Protein: 3ERT.oeb (click in ‘browse’ and go one
directory up, Figure 5a, number 3)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l5 level1 lfo10'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Reference ligand: ohtamoxifen.mol2 (click in
‘browse’)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l5 level1 lfo10'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Docking results: consensus_docked.mol2 (click in
‘browse’ and click on ‘result’)</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Note that the OHtamoxifen
appears on the top 10 list. Find estradiol and dihydrotestosterone in
consensus_scores.txt and observe that these compounds had bad results (at the
end of the list).</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='margin-left:.5in;text-align:justify;text-indent:-.25in;
line-height:115%;mso-list:l3 level1 lfo9'><![if !supportLists]><span
style='font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:
Wingdings'><span style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span><![endif]>Parameters to use in VIDA after running the
docking program for AR target:</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l2 level1 lfo11'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Protein: *.oeb (click in ‘browse’ and go one
directory up, Figure 2a, number 3)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l2 level1 lfo11'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Reference ligand: dihydrotestosterone.mol2
(click in ‘browse’)</p>

<p class=MsoNormal style='margin-left:.75in;text-align:justify;text-indent:
-.25in;line-height:115%;mso-list:l2 level1 lfo11'><![if !supportLists]><span
style='font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]>Docking results: consensus_docked.mol2 (click in
‘browse’ and click on ‘result’)</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Check if the
results are good or not. OHtamoxifen was at the end of the list. It is
expected, once that it not AR binder. Now compare estradiol and
dihydrotestosterone. Are they ranked well according to what you already now
about these ligands? Try to figure out what is happening with estradiol and
dihydrotestosterone in relation to AR binding.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><b
style='mso-bidi-font-weight:normal'>2.2 FlexX<o:p></o:p></b></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>This program is
slower than FRED because the conformation of each compound changes on-the-fly
(i.e. the conformation is changed while the program is running the
calculation). In fact, FlexX uses another concept, based on cutting the
compound in pieces, docking the anchor points and assembling these parts to re-generate
the compound. This is known as dynamic change of the conformation in part, once
that only the ligand can change its conformation during the interaction with
the rigid receptor.</p>

<p class=MsoNormal style='text-align:justify;line-height:115%'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='text-align:justify;line-height:115%'>The procedure is
also straightforward. Being connected to hatch.health.unm.edu, your account, go
to the FlexX directory: <b style='mso-bidi-font-weight:normal'>cd
tutorial_docking/FlexX</b>. Again, three directories with the targets’ files
are prepared for running the study. The procedure for ERa target is given below
and is the same for the other two targets. Go to the <b style='mso-bidi-font-weight:
normal'>ERa</b> directory. The following files are available: (i) 3ERT.rdf,
which is the receptor definition file, (ii) 3ERT.pdb, which is the original
receptor, (iii) 3ERT_surf.sdf, which is the surface created to the pocket, and
(iv) 3ERT_poc65.pdb, which is the pocket generated by considering all amino
acids at 6.5 Å distance from the ligand ohtamoxifen.mol2. The script.bat file
has all the information to run the calculation, which is based on the
definition file (config.dat). The compound database is located on the directory
/tutorial_docking/compounds.</p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l0 level1 lfo13'>Type
     the command <b><span style='font-size:11.0pt;line-height:115%'>flexx</span></b></li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l0 level1 lfo13'>Run
     the program by typing: <b><span style='font-size:11.0pt;line-height:115%'>script
     script</span></b></li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l0 level1 lfo13'>Wait
     until the end of calculation and close the program by typing <b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:115%'>quit</span></b>.</li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l0 level1 lfo13'>Open
     VIDA to analyze the results (type <b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'>vida</span></b> in the shell)</li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l0 level1 lfo13'>Go
     to: <i style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;
     line-height:115%'>Tools</span></i><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'> &gt; </span></b><i
     style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;
     line-height:115%'>FRED View</span></i><b style='mso-bidi-font-weight:normal'><span
     style='font-size:11.0pt;line-height:115%'><o:p></o:p></span></b></li>
 <li class=MsoNormal style='text-align:justify;line-height:115%;mso-list:l0 level1 lfo13'>Click
     in <i style='mso-bidi-font-style:normal'>browse</i> to find the Protein
     receptor file: 3ERT.pdb; Reference Ligand: ohtamoxifen.mol2; Results: *.*<b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:115%'><o:p></o:p></span></b></li>
</ul>

<p class=MsoNormal style='text-align:justify;line-height:115%'>Use the left
button of the mouse to rotate the complex and the middle one to zoom in and out.
Note that the docking result is much better when FlexX was used for
hydroxytamoxifen, but in the same time the calculation took longer because the
conformation is interactively changed to fit the target when docking into the
ERa site (remember that FRED uses a set of conformations previously generated
to dock).</p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>Follow
the same steps for ERRg. Go to the <b style='mso-bidi-font-weight:normal'>ERRg</b>
directory (<b style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
line-height:115%'>cd tutorial_docking/FlexX/ERRg/</span></b>) and list the
files (<b style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
line-height:115%'>ls</span></b>). The receptor files are as follow: (i)
2GPU.pdb, the original file with the coordinates of the receptor, (ii) 2GPU_poc65.pdb
that defines the pocket size of the receptor, (iii) 2GPU.rdf, the receptor
file, and (iv) 2GPU_surf.sdf, which is the surface of the receptor. The ligand
file, ohtamoxifen.mol2, is the reference compound.</p>

<p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:115%'>Finally,
do the same to AR and analyze all results, comparing with the FRED ones.</p>

</div>

<div style='mso-element:endnote-list'><![if !supportEndnotes]><br clear=all>

<hr align=left size=1 width="33%">

<![endif]>

<div style='mso-element:endnote' id=edn1>

<p class=MsoNormal style='text-align:justify'><a style='mso-endnote-id:edn1'
href="Docking.htm#_ednref1" name="_edn1" title=""><span class=MsoEndnoteReference><span
style='font-size:10.0pt'><span style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:10.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[1]</span></span><![endif]></span></span></span></a><span
style='font-size:10.0pt'> Norman, A. W.; Mizwicki, M. T.; Norman, D. P. G.;
Steroid-Hormone Rapid Actions, Membrane Receptors and a Conformational Ensemble
Model, <i style='mso-bidi-font-style:normal'>Nature Reviews Drug Discovery </i><b
style='mso-bidi-font-weight:normal'>2004</b>, <i style='mso-bidi-font-style:
normal'>3</i>, 27-41<o:p></o:p></span></p>

</div>

<div style='mso-element:endnote' id=edn2>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn2' href="Docking.htm#_ednref2"
name="_edn2" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[2]</span></span><![endif]></span></span></a> K<sub>i</sub>
and EC<sub>50</sub> data extracted from WOMBAT2006.2, Sunset Molecular Discovery
LLC.</p>

</div>

<div style='mso-element:endnote' id=edn3>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn3' href="Docking.htm#_ednref3"
name="_edn3" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[3]</span></span><![endif]></span></span></a> Bologa,
C. G.; Revankar, C. M.; Young, S. M.; Edwards, B. S.; Arterburn, J. B.;
Kiselyov, A. S.; Parker, M. A.; Tkachenko, S. E.; Savchuck, N. P.; Sklar, L.
A.; Oprea, T. I.; Prossnitz, E. R.; Virtual and Biomolecular Screening converge
on a Selective Agonist for GPR30, <i style='mso-bidi-font-style:normal'>Nature
Chemical Biology</i> <b style='mso-bidi-font-weight:normal'>2006</b>, <i
style='mso-bidi-font-style:normal'>2</i>, 207-212</p>

</div>

<div style='mso-element:endnote' id=edn4>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn4' href="Docking.htm#_ednref4"
name="_edn4" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[4]</span></span><![endif]></span></span></a> http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf</p>

</div>

<div style='mso-element:endnote' id=edn5>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn5' href="Docking.htm#_ednref5"
name="_edn5" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[5]</span></span><![endif]></span></span></a> Taplin,
M.-E.; Drug Insight: Role of the Androgen Receptor in the Development and
Progression of Prostate Cancer, <i style='mso-bidi-font-style:normal'>Nature Clinical
Practice Oncology </i><b style='mso-bidi-font-weight:normal'>2007</b>, <i
style='mso-bidi-font-style:normal'>4</i>, 236-244</p>

</div>

<div style='mso-element:endnote' id=edn6>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn6' href="Docking.htm#_ednref6"
name="_edn6" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[6]</span></span><![endif]></span></span></a> Gao, W.;
Bohl, C. E.; <st1:City w:st="on"><st1:place w:st="on">Dalton</st1:place></st1:City>,
J. T.; Chemistry and Structural Biology of Androgen Receptor, <i
style='mso-bidi-font-style:normal'>Chemical Reviews</i> <b style='mso-bidi-font-weight:
normal'>2005</b>,<i style='mso-bidi-font-style:normal'> 105</i>, 3352-3370</p>

</div>

<div style='mso-element:endnote' id=edn7>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn7' href="Docking.htm#_ednref7"
name="_edn7" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[7]</span></span><![endif]></span></span></a> Blizzard,
T. A.; Gude, C.; Chan, W.; Birzin, E. T.; Mojena, M.; Tudela, C.; Chen, F.;
Knecht, K.; Su, Q.; Kraker, B.; Holmes, M. A.; Rohrera, S. P.; Hammond, M. L.;
Bridged androstenediol analogs as ER-b selective SERMs, <i style='mso-bidi-font-style:
normal'>Bioorganic &amp; Medicinal Chemistry Letters </i><b style='mso-bidi-font-weight:
normal'>2007</b>, <i style='mso-bidi-font-style:normal'>17</i>, 2944–2948</p>

</div>

<div style='mso-element:endnote' id=edn8>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn8' href="Docking.htm#_ednref8"
name="_edn8" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[8]</span></span><![endif]></span></span></a> Menezes,
<st1:place w:st="on">I.</st1:place> R. A; Leitão, A.; Montanari, C. A.;
Three-Dimensional Models of Non-Steroidal Ligands: A Comparative Molecular
Field Analysis,<i style='mso-bidi-font-style:normal'> Steroids</i> <b
style='mso-bidi-font-weight:normal'>2006</b>, <i style='mso-bidi-font-style:
normal'>71</i>, 417-428</p>

</div>

<div style='mso-element:endnote' id=edn9>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn9' href="Docking.htm#_ednref9"
name="_edn9" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'>[9]</span></span><![endif]></span></span></a> Ariazi,
E. A.; et al. <strong><span style='font-weight:normal'>Exemestane’s
17-hydroxylated</span> </strong><strong><span style='font-weight:normal'>Metabolite
Exerts Biological</span> E</strong><strong><span style='font-weight:normal'>ffects
as an Androgen, <i>Mol. Cancer Ther.</i> </span>2008</strong><strong><span
style='font-weight:normal'> <i>in press</i></span></strong></p>

</div>

</div>

</body>

</html>
